PRRT2 and neoplasm: One study demonstrated that small molecule ligands of NONO could inhibit oncogenic transcription networks.536 However, in TNBC, NONO can detect overexpressed moesin (MSN) in the cytoplasm of tumor cells, forming a PKC-MSN-NONO complex that translocates to the nucleus, thereby activating CREB signaling and promoting tumor progression.